Home › Hypoparathyroidism › Nevada › Reno
Hypoparathyroidism clinical trials in Reno, NV
3 studies for Hypoparathyroidism are looking for participants at sites in and around Reno (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
RecruitingPhase 3
- Ascendis Pharma Investigational Site, Reno
A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
RecruitingPhase 3
- MBX Biosciences Investigational Site, Reno
Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism
RecruitingPhase 3
- Calcilytix Therapeutics, Inc., a BridgeBio Company, Investigational Site, Reno
Hypoparathyroidism trials in other cities
Other studies in Reno
- Non-Small Cell Lung Cancer16 studies
- Breast Cancer13 studies
- Lung Cancer9 studies
- Macular Degeneration8 studies
- Geographic Atrophy8 studies
- Ovarian Cancer7 studies
- Cancer (all types)7 studies
- Colorectal Cancer5 studies
- Acute Myeloid Leukemia5 studies
- Metastatic Cancer5 studies
- Pancreatic Cancer5 studies
- Colon Cancer5 studies
From ClinicalTrials.gov, data retrieved Oct 4, 2026. Each study sets its own eligibility; the study team decides who can join.